Business Standard

Kilitch Drugs (India) Share Price

Know More
NSEBSE

348.75-1.05 (-0.30%)

11:58 AM,16th Apr 2024

348.651.65 (0.48%)

12:12 PM,16th Apr 2024

BSE : 524500

NSE : KILITCH

Sector : Health care

ISIN Code : INE729D01010

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Apr 16 2024 | 12:12 PM IST

Market Cap (₹ Cr)

560

Turnover (₹ Cr)

0.01

Volume (Shares)

2700

Face Value

10

52-WK High

470.00

52-WK High Date

08 Feb 2024

52-WK Low

157.20

52-WK Low Date

18 Apr 2023

All Time High

470.00

All Time High Date

08 Feb 2024

All Time Low

17.00

All Time Low Date

13 Jun 2013

Kilitch Drugs (India) Ltd

Kilitch Drugs (India) Limited (KDIL) was incorporated in May 1992 as a public limited company. The Company is a pharmaceutical company engaged in development manufacturing and marketing of quality finished dosages. The Company is one of the most reliable manufacturer of injectables in India and one of the largest manufacturer of cephalosporins in Africa having its manufacturing unit located in India and Ethiopia. Its services range from manufacturing to marketing a host of formulations in all dosage forms i.e. solid liquid and parenteral forms of creating safe pharmaceutical solutions.The Company went public in Feb.'94 to set up a pharmaceutical formulation plant at Thane to manufacture pharmaceutical products in the form of tablets capsulesliquid orals ointments creams and injectables. Even before the plant was commissioned the company came out with a rights issue in Oct.'95 to expand the injectible capacity. Commercial production at the plant at Thane commenced in 1996. The company has two divisions - O T C and ethical.A Pharmaceutical formulation plant at Sana'a Republic of Yemen was set up at a cost of Rs 15 crore by entering into an agreement with Al-Fath Trading Corporation.It also entered into an agreement with a Miami company for the export of their medicine to West Indies south and central America.The company entered into a contract with one of the leading company in the Republic of Yemen which it had set up at a cost of Rs 2.5-cr tanning unit which was implemented in the year 1995-96. The company had set up a bulk drug unit at Patalganga Maharashtra for producing raw materials for formulations. The company exports to Sudan Yemen middle-east Miami and certain south American companies. KDIL started marketing a range of injectables from the factory on ethical basis. The company also introduced a new product clue-plus Bon-Bon Gripe Water and Kilitch Balm.The Company launched a new product 'BENIN' in the market in 2011. During the year 2011-12 the Company sold its business located at Paonta Sahib Himachal Pradesh as a going concern on a slump sale basis along with transfer of services set forth in the Business Transfer Agreement (BTA). The undertaking was sold and transferred on 28th February 2012 after getting all the necessary clearances as indicated in the BTA. It retained its Name Trademark (Kilitch) and all other properties and assets at Mumbai. It transferred certain products by entering into a Product Transfer Agreement (PTA) with Akorn India Pvt. Ltd. (AIPL) by which the right to manufacture certain products by the Company at Mumbai were sold to AIPL.

Kilitch Drugs (India) Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

560

EPS - TTM (₹) [S]

11.85

P/E Ratio (X) [S]

2.65

Face Value (₹) 10
Latest Dividend (%)5.00
Latest Dividend Date 20 Sep 2019
Dividend Yield (%) -
Book Value Share (₹) [S]131.60
P/B Ratio (₹) [S]2.65
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High

343.25

365.05

Week Low/High

343.25

387.00

Month Low/High

343.25

400.00

Year Low/High

157.20

470.00

All time Low/High

0.75

470.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-6.29%-5.78%-2.30-2.10%
1 Month-3.49%-4.44%0.440.65%
3 Month-13.45%-13.11%-0.220.61%
6 Month32.58%32.53%10.2712.34%
1 Year107.22%107.77%20.7424.33%
3 Year239.91%236.31%49.4251.64%

Company Info

Company Information

Chairman & Managing Director : Mukund P Mehta

Whole-time Director : Bhavin M Mehta

Independent Director : Hemang Engineer

Whole-time Director : Mira Bhavin Mehta

Independent Director : Murti Vasudev Krishna

Independent Director : Venkita Subramanian Rajan

Company Sec. & Compli. Officer : Pushpa Nyoupane

Registered Office: C-301/2 MIDC TTC Indl Area, Pawane Village,Thane,Maharashtra-400705 Ph: 91-022-27670322/27680913/65144185

Email:info@kilitch.com

URL:http://www.kilitch.com